FDA.reportPublic FDA data

immune globulin intravenous (human) - ifas 10 % in 200 ML Injection

RxCUI
2102469
RxNorm name
immune globulin intravenous (human) - ifas 10 % in 200 ML Injection
Display name
immune globulin intravenous (human) - ifas 10 % in 200 ML Injection
Full name
immune globulin intravenous (human) - ifas 10 % in 200 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:02

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125587PanzygaImmune Globulin Intravenous (Human)-ifas351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
68a5ee5f-0352-b3ae-3321-c0a22947a31dimmune globulin intravenous (human) - ifas 10 % per 200 ML InjectionSY11These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820210215
68a5ee5f-0352-b3ae-3321-c0a22947a31d200 ML immune globulin intravenous (human) - ifas 100 MG/ML InjectionSCD11These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820210215
68a5ee5f-0352-b3ae-3321-c0a22947a31dimmune globulin intravenous (human) - ifas 10 % in 200 ML InjectionPSN11These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820210215
e2cc5ddf-119e-ade3-79c2-c712cfbee099immune globulin intravenous (human) - ifas 10 % per 200 ML InjectionSY10These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508
e2cc5ddf-119e-ade3-79c2-c712cfbee099immune globulin intravenous (human) - ifas 10 % in 200 ML InjectionPSN10These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508
e2cc5ddf-119e-ade3-79c2-c712cfbee099200 ML immune globulin intravenous (human) - ifas 100 MG/ML InjectionSCD10These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508
9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0200 ML immune globulin intravenous (human) - ifas 100 MG/ML InjectionSCD2These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508
9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0immune globulin intravenous (human) - ifas 10 % per 200 ML InjectionSY2These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508
9306c5f7-ddf9-5190-d0c1-31ba9ca2d0e0immune globulin intravenous (human) - ifas 10 % in 200 ML InjectionPSN2These highlights do not include all the information needed to use PANZYGA safely and effectively. See full prescribing information for PANZYGA. PANZYGA, (immune globulin intravenous, human - ifas) 10% Liquid Preparation Initial U.S. Approval: 201820250508